article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. It has potential to be applied simply and directly to most existing commercial vaccines. 2011;29:7122–7124. Sharma D, Khamar S, Cullen A, et al.

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

presented their pathway for regulatory approval to the FDA Vaccines and Related Biological Products Advisory Committee for a faecal microbiota-based live biotherapeutic to treat recurrent Clostridioides difficile infection, which is a major Healthcare Acquired Infection (HAI). For example, in September 2022, the company Rebiotix, Inc.